Expert Analyses of Key Clinical Developments and Updates Across Gynecologic Malignancies

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.00
2022 ESGO Congress: Experts Discuss HRD Testing, PARP Inhibitors in Recurrent Ovarian Cancer, and QoL in Nonepithelial Ovarian Cancer

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Expert Thoughts on Studies of Interest Presented at the 2022 ESGO Annual Meeting on Gynecologic Cancers

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
CCO 2022 Global Conference Coverage: Gynecologic Cancer Updates

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Optimizing Frontline Therapy in Ovarian Cancer Using PARP Inhibitors: A Video Roundtable

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Optimizing Frontline Therapy in Ovarian Cancer Using PARP Inhibitors: A Video Roundtable

Content Format:

Video

Credit Type:

AMA

Credits:

0.75
Precision Medicine in Ovarian Cancer: Understanding the Evolving Role of PARP Inhibitors

Content Format:

Multimedia

Credit Type:

--

Credits:

--
How to decide when to use different PARPi

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
An Expert Roundtable Exploring Recent Data in Ovarian Cancer and its Impact on Patient Care

Content Format:

Video

Credit Type:

--

Credits:

--
Optimizing the Use of PARP Inhibitors for the Treatment of Patients With Ovarian Cancer

Content Format:

Slideset Download

Credit Type:

--

Credits:

--